本页面由Tiger Trade Technology Pte. Ltd.提供服务

Janux Therapeutics, Inc.

13.85
+0.82006.29%
成交量:56.08万
成交额:767.37万
市值:8.43亿
市盈率:-7.55
高:13.91
开:13.32
低:13.32
收:13.03
52周最高:35.34
52周最低:12.12
股本:6,083.17万
流通股本:4,168.06万
量比:0.69
换手率:1.35%
股息:- -
股息率:- -
每股收益(TTM):-1.8336
每股收益(LYR):-1.8336
净资产收益率:-11.48%
总资产收益率:-9.55%
市净率:0.88
市盈率(LYR):-7.55

数据加载中...

2024/10/22

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities